INSECTICID — Insecticides (India) Balance Sheet
0.000.00%
- IN₹20.20bn
- IN₹20.06bn
- IN₹19.66bn
- 91
- 48
- 66
- 80
Annual balance sheet for Insecticides (India), fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 741 | 682 | 361 | 196 | 614 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 3,695 | 3,259 | 3,147 | 3,376 | 3,621 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 9,783 | 10,861 | 10,027 | 12,322 | 12,482 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | 2,670 | 2,863 | 3,326 | 3,722 | 4,107 |
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 12,944 | 14,259 | 13,962 | 16,963 | 17,135 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 5,393 | 5,845 | 5,078 | 7,595 | 6,563 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 5,627 | 6,056 | 5,266 | 7,780 | 7,000 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 7,317 | 8,204 | 8,696 | 9,183 | 10,135 |
Total Liabilities & Shareholders' Equity | 12,944 | 14,259 | 13,962 | 16,963 | 17,135 |
Total Common Shares Outstanding |